SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹87 Cr | ₹78 Cr | ₹75 Cr | ₹35 Cr | ₹36 Cr |
What is the latest Total Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹78 Cr |
| Mar2023 | ₹75 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹36 Cr |
How is Total Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | 11.48 | |
| Mar2024 | ₹78 Cr | 3.83 | |
| Mar2023 | ₹75 Cr | 113.50 | |
| Mar2022 | ₹35 Cr | -1.39 | |
| Mar2021 | ₹36 Cr | - | |
Compare Total Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,491.0 Cr | -17.7% | -9.1% | 48% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,555.0 Cr | -1.5% | 1.6% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,889.0 Cr | -2% | -4.3% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,073.0 Cr | -0.8% | 0.5% | 32% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,133.0 Cr | -2.7% | -1.6% | 6.9% | Stock Analytics | |
| CIPLA | ₹98,492.9 Cr | -3.9% | -9.1% | -18.4% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | -17.7% |
-9.1% |
48% |
| SENSEX | -2.6% |
-10.2% |
-1.6% |
You may also like the below Video Courses